Experienced in Orchiectomy

Dr. Arafat H. Tfayli

Hematology Oncology | Hematology | Oncology
825 Ne 10th St, Oupb 5200, 
Oklahoma City, OK 
Accepting New Patients
Experienced in Orchiectomy
825 Ne 10th St, Oupb 5200, 
Oklahoma City, OK 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Arafat Tfayli is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Tfayli is rated as an Experienced provider by MediFind in Orchiectomy. His top areas of expertise are Lung Adenocarcinoma, Breast Cancer, Lung Cancer, Tissue Biopsy, and Orchiectomy. Dr. Tfayli is currently accepting new patients.

His clinical research consists of co-authoring 98 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Orchiectomy.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in OK
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

825 Ne 10th St, Oupb 5200, Oklahoma City, OK 73104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Pemetrexed, Paclitaxel, Gemcitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Enrollment Status: Completed
Publish Date: October 28, 2021
Intervention Type: Drug
Study Phase: Phase 3
Randomized Multicenter Study to Compare the Effectiveness and Safety of Erlotinib and Pemetrexed as Maintenance Therapy of Advanced Non-Squamous Non-Small Cell Lung Cancer
Randomized Multicenter Study to Compare the Effectiveness and Safety of Erlotinib and Pemetrexed as Maintenance Therapy of Advanced Non-Squamous Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: March 05, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

98 Total Publications

Factors Influencing the Delay in Head and Neck Cancer Diagnosis in Lebanon.
Factors Influencing the Delay in Head and Neck Cancer Diagnosis in Lebanon.
Journal: The Laryngoscope
Published: April 05, 2025
Similar Doctors
Experienced in Orchiectomy
Dr. Graca M. Dores
Hematology Oncology
Experienced in Orchiectomy
Dr. Graca M. Dores
Hematology Oncology
921 Ne 13th St, Veterans Affairs Medical Center, 
Oklahoma City, OK 
 (0.4 miles away)
405-270-0501
Languages Spoken:
English

Graca Dores is a Hematologist Oncology provider in Oklahoma City, Oklahoma. Dr. Dores is rated as an Experienced provider by MediFind in Orchiectomy. Her top areas of expertise are Hodgkin Lymphoma, Myelodysplastic Syndrome (MDS), Leukemia, Non-Hodgkin Lymphoma, and Orchiectomy.

Experienced in Orchiectomy
Dr. Fadi Gebrail
Hematology
Experienced in Orchiectomy
Dr. Fadi Gebrail
Hematology

Pathology Group PC

4300 W Memorial Rd, 
Oklahoma City, OK 
 (10.5 miles away)
405-272-7065
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Fadi Gebrail is a Hematologist in Oklahoma City, Oklahoma. Dr. Gebrail is rated as an Experienced provider by MediFind in Orchiectomy. His top areas of expertise are Anemia, Gallbladder Disease, Non-Hodgkin Lymphoma, Small Lymphocytic Lymphoma (SLL), and Orchiectomy. Dr. Gebrail is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tfayli's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile